Home

GV 2016 GP, L.P.

CIK 1722204 · last filed 2025-05-19

GV 2016 GP, L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2017. Current disclosed insider exposure totals $74.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$74.42M

Companies

3

Total Filings

4

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted 10%+ Owner 3,339,137 $11.19 $37.38M $0 1 2018-06-27
RCUS 10%+ Owner 3,125,312 $23.80 $74.38M $0 1 2018-03-19
ASNS 10%+ Owner 451,362 $0.08 $35.2K $0 1 2017-11-20

Recent Filings

4 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-05-19 — Other (J) +191,920,624 $0
2018-06-27 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Conv (C) +13,356,548 $0 EDGAR
2018-03-19 RCUS Conv (C) +12,501,248 $0 EDGAR
2017-11-20 ASNS Conv (C) +1,805,448 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.